{"id":129690,"date":"2024-05-22T15:06:50","date_gmt":"2024-05-22T13:06:50","guid":{"rendered":"https:\/\/prod1-sb.designtech.space\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/"},"modified":"2024-05-22T15:06:50","modified_gmt":"2024-05-22T13:06:50","slug":"bristol-meyers-squibb-enters-neophore-series-b-round","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/","title":{"rendered":"Bristol Meyers Squibb Enters NeoPhore Series B Round"},"content":{"rendered":"<p>NeoPhore, a biotech company active in the development of small molecules in the field of immuno-oncology, announces that <strong>Bristol Myers Squibb has joined the extension of the Series B investment round which has a total value of 35 million British pounds<\/strong>.<\/p>\n<p><strong>The additional funding from BMS will enable NeoPhore to further explore the biology behind DNA mismatch repair<\/strong> (&#8216;MMR&#8217;) in cancer, as well as further advance preclinical studies and identify a drug candidate in 2025.<\/p>\n<p>NeoPhore focuses on building a pipeline of small molecules that inhibit MMR pathway proteins to generate next-generation immuno-oncology therapies and contribute to the improvement of current cancer care. NeoPhore drugs induce the expression of neoantigens and increase the immunogenicity of solid tumors, thereby making them sensitive to immunotherapy.<\/p>\n<p><strong>Robert James, chairman of NeoPhore, said in a statement: &#8220;Bristol Myers Squibb&#8217;s entry validates NeoPhore&#8217;s innovative approach that aims to inhibit the MMR pathway with small molecules for cancer treatment.<\/strong> In light of NeoPhore&#8217;s achievements in 2023, we look forward to seeing a year of progress for the company&#8217;s preclinical programs.&#8221;<\/p>\n<p>The Series B round and its extension saw the participation of numerous Italian investors, including the <strong>biotech fund Claris Ventures, Neva, Liftt, private investors belonging to the Club degli Investitori network and Italian Angels for Growth and Simon Fiduciaria of the Ersel Group. <\/strong><em>(image from NeoPhore&#8217;s website)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The British biotech closes the round at \u00a335 million with the participation of Italian investors Claris, Neva, Liftt, Club degli investitori, IAG<\/p>\n","protected":false},"author":125,"featured_media":137268,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1346,1345],"tags":[1350,1144,1323,1136],"companies":[],"journalist":[1513],"class_list":["post-129690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-must-read","category-scaleup","tag-biotech-en","tag-europe-en","tag-scaleup-en","tag-startup-en-2","journalist-emil-abirascid-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","width":150,"height":71,"crop":false,"srcset":false,"alt":""},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","width":1024,"height":487,"crop":false,"srcset":false,"alt":""},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","width":1174,"height":558,"crop":false,"srcset":false,"alt":""}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bristol Meyers Squibb Enters NeoPhore Series B Round<\/title>\n<meta name=\"description\" content=\"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol Meyers Squibb Enters NeoPhore Series B Round\" \/>\n<meta property=\"og:description\" content=\"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T13:06:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1174\" \/>\n\t<meta property=\"og:image:height\" content=\"558\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"Bristol Meyers Squibb Enters NeoPhore Series B Round\",\"datePublished\":\"2024-05-22T13:06:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/\"},\"wordCount\":231,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Screenshot-2024-05-22-alle-17.05.39.jpg\",\"keywords\":[\"biotech\",\"Europe\",\"Scaleup\",\"startup\"],\"articleSection\":[\"Must Read\",\"Scaleup\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/\",\"name\":\"Bristol Meyers Squibb Enters NeoPhore Series B Round\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Screenshot-2024-05-22-alle-17.05.39.jpg\",\"datePublished\":\"2024-05-22T13:06:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/bristol-meyers-squibb-enters-neophore-series-b-round\\\/129690\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Screenshot-2024-05-22-alle-17.05.39.jpg\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Screenshot-2024-05-22-alle-17.05.39.jpg\",\"width\":1174,\"height\":558},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol Meyers Squibb Enters NeoPhore Series B Round","description":"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/","og_locale":"en_US","og_type":"article","og_title":"Bristol Meyers Squibb Enters NeoPhore Series B Round","og_description":"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG","og_url":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/","og_site_name":"Startupbusiness.it","article_published_time":"2024-05-22T13:06:50+00:00","og_image":[{"width":1174,"height":558,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","type":"image\/jpeg"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"Bristol Meyers Squibb Enters NeoPhore Series B Round","datePublished":"2024-05-22T13:06:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/"},"wordCount":231,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","keywords":["biotech","Europe","Scaleup","startup"],"articleSection":["Must Read","Scaleup"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/","url":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/","name":"Bristol Meyers Squibb Enters NeoPhore Series B Round","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","datePublished":"2024-05-22T13:06:50+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"The British biotech closes the round at \u00a335M with the participation of the Italians Claris, Neva, Liftt, Club degli investitori, IAG","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/bristol-meyers-squibb-enters-neophore-series-b-round\/129690\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/Screenshot-2024-05-22-alle-17.05.39.jpg","width":1174,"height":558},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Must Read","Scaleup"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=129690"}],"version-history":[{"count":0,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/137268"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=129690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=129690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=129690"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=129690"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=129690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}